Cart
sales@molnova.com
N-Methylcytisine
CAS No. 486-86-2
N-Methylcytisine( Caulophylline )
Catalog No. M18630 CAS No. 486-86-2
N-Methylcytisine and N, N-dimethylcytisine did not displace 14C-tubocurarine at a concentration of .1 mM, cytisine was the only effective inhibitor of 14C-tubocurarine specific binding (Ki=7 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 116 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 350 | In Stock |
|
| 50MG | 516 | In Stock |
|
| 100MG | 752 | In Stock |
|
| 500MG | 1512 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Methylcytisine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Methylcytisine and N, N-dimethylcytisine did not displace 14C-tubocurarine at a concentration of .1 mM, cytisine was the only effective inhibitor of 14C-tubocurarine specific binding (Ki=7 nM).
-
DescriptionN-Methylcytisine's nicotinic receptors have high affinity (KD = 5 nM)to nAChR from squid optical ganglia. N-Methylcytisine and N, N-dimethylcytisine did not displace 14C-tubocurarine at a concentration of .1 mM, cytisine was the only effective inhibitor of 14C-tubocurarine specific binding (Ki=7 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsCaulophylline
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number486-86-2
-
Formula Weight204.27
-
Molecular FormulaC12H16N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 120 mg/mL (587.46 mM)
-
SMILESCN1CC2CC(C1)C3=CC=CC(=O)N3C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Artesunate
Artesunate is a part of the artemisinin group of agents with an IC50 of < 5 μM for small cell lung carcinoma cell line H69.
-
GPA 512
The orally bioavailable prodrug of Galiellalactone, a direct inhibitor of STAT3, prevents the transcription of STAT3 regulated genes.
-
HJC0152
A potent, orally bioavailable STAT3 signaling inhibitor that exhibits promising antitumor effects in vitro and in vivo.
